Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· January 23, 2026

AI in Medical Imaging Market Size to Hit Nearly USD 22.97 Trillion by 2035, Driven by Rising Demand for Early Disease Detection and Workflow Automation

View original at globenewswire.com
AI in Medical Imaging Market Size to Hit Nearly USD 22.97 Trillion by 2035, Driven by Rising Demand for Early Disease Detection and Workflow Automation Ottawa, Jan…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Over $3 billion in private funding has gone to AI imaging startups in the past 5 years

    80% confidence
  • North America holds 45% share of AI medical imaging market in 2025, the largest regional share

    80% confidence
  • There is a 30-40% global radiologist workforce shortage

    80% confidence
  • Asia-Pacific is the fastest growing region at 30.80% CAGR

    80% confidence
  • AI is present in approximately 35% of large hospitals as of 2025

    80% confidence
  • U.S. AI medical imaging market will grow from $716.22B in 2025 to $7,640.97B in 2034 at 26.71% CAGR

    80% confidence
  • Deep learning holds 48% market share with $970.58B revenue in 2025, the dominant technology

    80% confidence
  • Global AI in medical imaging market will grow from $2.01 trillion in 2025 to $22.97 trillion in 2035 at 27.57% CAGR

    80% confidence
  • China accounts for over 35% of Asia-Pacific AI medical imaging growth

    80% confidence
  • 70% of global deaths are from chronic diseases including cancer, cardiovascular, neurological, and respiratory conditions

    80% confidence
  • Explainable AI is the fastest growing technology segment at approximately 30% CAGR

    80% confidence
  • AI delivers 30-50% reduction in reporting turnaround time and 20-30% improvement in diagnostic accuracy

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com